Urinary apolipoprotein (a) excretion in patients with proteinuria

Annals of Medicine

Volumn 30, Issue 5, 1998, Pages 497-502

  Kostner, Karam M ^a,b   Banyai, Susanne ^a   Banyai, Martin ^a   Bodlaj, Gert ^a   Maurer, Gerald ^a   Derfler, Kurt ^a   Hörl, Walter H ^a   Oberbauer, Rainer ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Plasma lipoprotein (a); Proteinuria; Urinary apolipoprotein (a)

Indexed keywords

APOLIPOPROTEIN A; CREATININE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; HUMAN; KIDNEY FUNCTION; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; URINARY EXCRETION;

EID: 0031756129     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899809002492     Document Type: Article

References (24)

1. Berg K, Dahlen G, Frick MH. Lp(a) lipoprotein and pre-β1-lipoprotein in patients with coronary heart disease. Clin Genet 1974; 6: 230-5.
2. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Qunici GB. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981; 38: 51-61.
3. Armstrong VW, Cremer P, Eberle E, et al. The associaton between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 1986; 62: 249-57.
4. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyana M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Dependence on serum LDL levels. Atherosclerosis 1986; 59: 199-204.
5. Cushing GL, Gaubatz JW, Nava ML, et al. Quantitation and localization of apolipoproteins (a) and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis 1989; 9: 593-603.
6. Cremer P, Nagel D, Labrot B, et al. Lipoprotein(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest 1994; 24: 444-53.
7. McLean JW, Tomlinson JE, Kuang WJ, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 330: 132-7.
8. Edelberg JM, Pizzo SV. Lipoprotein(a) inhibits plasminogen activation in a template-dependent manner. Blood Coagul Fibrinolysis 1991; 2: 759-64.
9. Bihari-Varga M, Gruber E, Rotheneder M, Zechner R, Kostner GM. Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis 1988; 8: 851-7.
10. Krempler F, Kostner GM, Bolzano K, Sandhofer F. Turnover of lipoprotein (a) in man. J Clin Invest 1980; 65: 1483-90.
11. Parra HJ, Mezdour H, Cachera C, Dracon M, Tacquet A, Fruchart JC. Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Clin Chem 1987; 33: 721.
12. Karadi I, Romics L, Palos G, et al. Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin. Clin Chem 1989; 35: 2121-3.
13. Faucher C, Doucet C, Baumelou A, Chapman J, Jacobs C, Thillet J. Elevated lipoprotein(a) levels in primary nephrotic syn-drome. Am J Kidney Dis 1993; 22: 808-13.
14. Thomas ME, Freestone A, Varghese Z, Persaud JW, Moorhead JF. Lipoprotein(a) in patients with proteinuria. Nephrol Dial Transplant 1992; 7: 597-601.
15. Ordonez JD, Hiatt RA, Killebrew EJ, Fireman BH. The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int 1993; 44: 638-42.
16. Appel GB, Blum CB, Chien S, Kunis CL, Appel AS. The hyperlipidemia of nephrotic syndrome. Relation to plasma . albumin concentration, oncotic pressure, and viscosity. N Engl J Med 1985; 312: 1544-8.
17. Oida K, Takai H, Maeda H, et al. Apolipoprotein(a) is present in urine and its excretion is decreased in patients with renal failure. Clin Chem 1992; 38: 2244-8.
18. Kostner K, Maurer G, Huber K, et al. Urinary excretion of apo(a) fragments. Role in apo(a) catabolism. Atherioscler Thromb Vasc Biol 1996; 16: 905-11.
19. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987; 80: 458-65.
20. Kostner KM, Oberbauer R, Hoffmann U, Stefenelli T, Maurer G, Watschinger B. Urinary excretion of apo(a) in patients after kidney transplantation. Nephrol Dial Transpl 1997; 12: 2673-8.
21. Kronenberg F, Utermann G, Dieplinger H. Lipoprotein(a) in renal disease. Am J Kidney Dis 1996; 27: 1-25.
22. Mooser V, Seabra MC, Abedin M, Landschulz KT, Marcovina S, Hobbs HH. Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a). J Clin Invest 1996; 97: 858-64.
23. Kostner K, Jansen M, Maurer G, Derfler K. LDL-apheresis significantly reduces urinary apo(a) excretion. Eur J Clin Invest 1997; 27: 93-5.
24. Scherberich JE. Urinary proteins of tubular origin: basic immunochemical and clinical aspects. Am J Nephrol 1990; 10 Suppl 1: 43-51.